Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>

Co-infection with carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) and <i>Pseudomonas aeruginosa</i> (CRPA) is associated with poor outcomes and historically relied on combination therapy with toxic agents for management. However, several novel β-lactam/β-lactamase in...

Full description

Bibliographic Details
Main Authors: Anthony Sophonsri, Michelle Kalu, Annie Wong-Beringer
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Antibiotics
Subjects:
carbapenem resistance
carbapenemase
multidrug-resistant organism
<i>Pseudomonas aeruginosa</i>
<i>Klebsiella pneumoniae</i>
KPC
Online Access:https://www.mdpi.com/2079-6382/13/5/416

Internet

https://www.mdpi.com/2079-6382/13/5/416

Similar Items